Rx Only

Ready for 24-48h Central Dispatch

In Stock

SENTRO Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download

SyrupPrescription Required (Schedule Drug)

SENTRO

Name: SENTRO
Brand: Sygnus Biotech

Active Drug Composition

Ondansetron Oral Solution 4mg/5ml

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

SENTRO (Ondansetron Oral Solution 4mg/5ml) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.

Dosage FormOral Liquid Suspension / Syrup

Packaging Presentation100ml / 200ml PET Bottle with Graduated Measuring Cap

B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Indicated for therapeutic management within specified clinical indications under qualified physician guidance.

Mechanism of Action (MOA)

The active pharmacological principles in SENTRO deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.

Dosage & Posology

As directed by the registered medical practitioner. Strictly adhere to full course duration.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup

Dosage FormOral Liquid Suspension / Syrup

Packaging Type100ml / 200ml PET Bottle with Graduated Measuring Cap

Regulatory ScheduleSchedule H

Minimum Order Qty100 Units

Country of OriginIndia (Sidhpur Facility)

Quality StandardWHO-GMP & ISO 9001:2015

Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

SENTRO features Ondansetron Oral Solution 4mg/5ml prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup

Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of SENTRO

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.

Distributor Inquiries

Questions Regarding SENTRO

What is the therapeutic indication and composition of SENTRO?

SENTRO contains Ondansetron Oral Solution 4mg/5ml indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.

What packaging presentations are available for SENTRO?

SENTRO is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for SENTRO?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for SENTRO along with promotional visual aids, product cards, and marketing support.